Market Overview

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mednax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm


Schall Law Firm
, a national shareholder rights litigation firm,
announces the filing of a class action lawsuit against Mednax, Inc.
("Mednax" or the "Company") (NYSE: MD)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
Exchange Commission.

Investors who purchased the Company's shares between February 4, 2016
and July 27, 2017, inclusive (the ''Class Period''), are encouraged to
contact the firm before September 10, 2018.

If you are a shareholder who suffered a loss, click
here to participate

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm's website at,
or by email at

The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading
statements to the market. Mednax's business model relied on acquiring
anesthesiology practice groups to drive growth. Because of this fact,
that growth was not sustainable, and the Company's growth was based on
maintaining lower wages for physicians and practice staff, and rigidly
enforcing non-compete agreements to discourage practice defections.
Mednax announced as part of its second-quarter earnings call, on July
28, 2017, that the Company had not acquired any anesthesiologist
practices in the quarter, and that it was unlikely the Company would
acquire practices in the future. Based on these facts, the Company's
public statements about operations and future results were false and
materially misleading throughout the class period. When the market
learned the truth about Mednax, investors suffered damages.

the case
to recover your losses.

The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.

View Comments and Join the Discussion!